An overlap case of Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

Koji Shinoda, Hiroyuki Murai, Ken Ichi Shibata, Shoko Samejima, Shuji Kaneto, Nobuyoshi Takashima, Kimihiro Tanaka

Research output: Contribution to journalLetter

2 Citations (Scopus)

Abstract

A 29-year-old female developed diplopia, nasal voice and gait disturbance after an upper respiratory infection. On admission, she presented with bilateral external ophthalmoplegia, slight bilateral facial nerve palsy, dysarthria, dysphagia cervical and brachial muscle weakness, ataxia and areflexia. She had serum anti-GT1a, anti-GQ1b and anti-galactocerebroside IgG antibodies. She was diagnosed with an overlap case of Fisher syndrome and pharyngeal-cervical- brachial variant of Guillain-Barré syndrome. Intravenous immunoglobulin therapy was effective for the ophthalmoplegia and ataxia, but did not improve the bilateral facial nerve palsy and brachial muscle weakness. The facial nerve palsy clearly worsened despite improvement in other symptoms, and therefore high-dose intravenous methylprednisolone therapy was added. The distinct response to treatment may be caused by different activity, production, clearance and reactivity to intravenous immunoglobulin of the autoantibodies. The present case suggests that treatment response and patterns of recovery differ according to the causative anti-ganglioside antibodies.

Original languageEnglish
Pages (from-to)30-33
Number of pages4
JournalClinical Neurology
Volume52
Issue number1
DOIs
Publication statusPublished - Feb 3 2012

Fingerprint

Miller Fisher Syndrome
Facial Paralysis
Facial Nerve
Ophthalmoplegia
Arm
Intravenous Immunoglobulins
Muscle Weakness
Ataxia
Voice Disorders
Dysarthria
Passive Immunization
Diplopia
Gangliosides
Methylprednisolone
Deglutition Disorders
Gait
Nose
Respiratory Tract Infections
Autoantibodies
Anti-Idiotypic Antibodies

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Shinoda, K., Murai, H., Shibata, K. I., Samejima, S., Kaneto, S., Takashima, N., & Tanaka, K. (2012). An overlap case of Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Clinical Neurology, 52(1), 30-33. https://doi.org/10.5692/clinicalneurol.52.30

An overlap case of Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. / Shinoda, Koji; Murai, Hiroyuki; Shibata, Ken Ichi; Samejima, Shoko; Kaneto, Shuji; Takashima, Nobuyoshi; Tanaka, Kimihiro.

In: Clinical Neurology, Vol. 52, No. 1, 03.02.2012, p. 30-33.

Research output: Contribution to journalLetter

Shinoda, K, Murai, H, Shibata, KI, Samejima, S, Kaneto, S, Takashima, N & Tanaka, K 2012, 'An overlap case of Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome', Clinical Neurology, vol. 52, no. 1, pp. 30-33. https://doi.org/10.5692/clinicalneurol.52.30
Shinoda, Koji ; Murai, Hiroyuki ; Shibata, Ken Ichi ; Samejima, Shoko ; Kaneto, Shuji ; Takashima, Nobuyoshi ; Tanaka, Kimihiro. / An overlap case of Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. In: Clinical Neurology. 2012 ; Vol. 52, No. 1. pp. 30-33.
@article{69e8a6269d65428e93425874403453a4,
title = "An overlap case of Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barr{\'e} syndrome",
abstract = "A 29-year-old female developed diplopia, nasal voice and gait disturbance after an upper respiratory infection. On admission, she presented with bilateral external ophthalmoplegia, slight bilateral facial nerve palsy, dysarthria, dysphagia cervical and brachial muscle weakness, ataxia and areflexia. She had serum anti-GT1a, anti-GQ1b and anti-galactocerebroside IgG antibodies. She was diagnosed with an overlap case of Fisher syndrome and pharyngeal-cervical- brachial variant of Guillain-Barr{\'e} syndrome. Intravenous immunoglobulin therapy was effective for the ophthalmoplegia and ataxia, but did not improve the bilateral facial nerve palsy and brachial muscle weakness. The facial nerve palsy clearly worsened despite improvement in other symptoms, and therefore high-dose intravenous methylprednisolone therapy was added. The distinct response to treatment may be caused by different activity, production, clearance and reactivity to intravenous immunoglobulin of the autoantibodies. The present case suggests that treatment response and patterns of recovery differ according to the causative anti-ganglioside antibodies.",
author = "Koji Shinoda and Hiroyuki Murai and Shibata, {Ken Ichi} and Shoko Samejima and Shuji Kaneto and Nobuyoshi Takashima and Kimihiro Tanaka",
year = "2012",
month = "2",
day = "3",
doi = "10.5692/clinicalneurol.52.30",
language = "English",
volume = "52",
pages = "30--33",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "1",

}

TY - JOUR

T1 - An overlap case of Fisher syndrome and pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

AU - Shinoda, Koji

AU - Murai, Hiroyuki

AU - Shibata, Ken Ichi

AU - Samejima, Shoko

AU - Kaneto, Shuji

AU - Takashima, Nobuyoshi

AU - Tanaka, Kimihiro

PY - 2012/2/3

Y1 - 2012/2/3

N2 - A 29-year-old female developed diplopia, nasal voice and gait disturbance after an upper respiratory infection. On admission, she presented with bilateral external ophthalmoplegia, slight bilateral facial nerve palsy, dysarthria, dysphagia cervical and brachial muscle weakness, ataxia and areflexia. She had serum anti-GT1a, anti-GQ1b and anti-galactocerebroside IgG antibodies. She was diagnosed with an overlap case of Fisher syndrome and pharyngeal-cervical- brachial variant of Guillain-Barré syndrome. Intravenous immunoglobulin therapy was effective for the ophthalmoplegia and ataxia, but did not improve the bilateral facial nerve palsy and brachial muscle weakness. The facial nerve palsy clearly worsened despite improvement in other symptoms, and therefore high-dose intravenous methylprednisolone therapy was added. The distinct response to treatment may be caused by different activity, production, clearance and reactivity to intravenous immunoglobulin of the autoantibodies. The present case suggests that treatment response and patterns of recovery differ according to the causative anti-ganglioside antibodies.

AB - A 29-year-old female developed diplopia, nasal voice and gait disturbance after an upper respiratory infection. On admission, she presented with bilateral external ophthalmoplegia, slight bilateral facial nerve palsy, dysarthria, dysphagia cervical and brachial muscle weakness, ataxia and areflexia. She had serum anti-GT1a, anti-GQ1b and anti-galactocerebroside IgG antibodies. She was diagnosed with an overlap case of Fisher syndrome and pharyngeal-cervical- brachial variant of Guillain-Barré syndrome. Intravenous immunoglobulin therapy was effective for the ophthalmoplegia and ataxia, but did not improve the bilateral facial nerve palsy and brachial muscle weakness. The facial nerve palsy clearly worsened despite improvement in other symptoms, and therefore high-dose intravenous methylprednisolone therapy was added. The distinct response to treatment may be caused by different activity, production, clearance and reactivity to intravenous immunoglobulin of the autoantibodies. The present case suggests that treatment response and patterns of recovery differ according to the causative anti-ganglioside antibodies.

UR - http://www.scopus.com/inward/record.url?scp=84863026683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863026683&partnerID=8YFLogxK

U2 - 10.5692/clinicalneurol.52.30

DO - 10.5692/clinicalneurol.52.30

M3 - Letter

C2 - 22260976

AN - SCOPUS:84863026683

VL - 52

SP - 30

EP - 33

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 1

ER -